在肉瘤中融合蛋白的功能分类
Marco Wachtel1, Didier Surdez2, Thomas G P Grünewald3,4,5,6
1Department of Oncology and Children's Research Center, University Children's Hospital, Steinwiesstrasse 75, CH-8032 Zurich, Switzerland.
融合蛋白驱动肉瘤的发展,可以在治疗上准. 本综述根据功能对这些肉瘤融合蛋白进行了分类,揭示了不同的机制和治疗机会.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 瘤是一种多样化的一组,由80多种癌症组成,起源于介质细胞组织.
- 近一半的肉瘤类型具有特定的染色体转位,从而产生瘤性融合蛋白.
- 这些融合蛋白是肉瘤发展的关键驱动因素和潜在的治疗点.
研究的目的:
- 审查关于肉瘤中的融合蛋白的当前知识.
- 根据其功能和作用机制对融合蛋白进行分类.
- 探索针对这些融合蛋白的治疗策略.
主要方法:
- 关于肉瘤融合蛋白的科学文章的文献综述.
- 将融合蛋白分为功能类别的分类 (激酶,表观遗传调节剂,转录因子).
- 分析融合蛋白机制及其与肉瘤亚型的关联.
主要成果:
- 融合蛋白被分为酶,表观遗传调节剂和转录因子.
- 转录因子融合发生在所有介质细胞系中,而另一些则更受血统限制.
- 激酶融合在纤维细胞/肌纤维细胞肉瘤中很常见;表观遗传融合与不清楚的分化有关.
- 具体的机制包括Polycomb对抗性和氨酸转移酶招募.
结论:
- 融合蛋白在瘤亚型中表现出不同的生物功能和机制.
- 了解这些差异和相似之处为功能分类提供了基础.
- 准融合蛋白活性为肉瘤治疗提供了一个有前途的治疗途径.
更多相关视频
09:58Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Published on: June 27, 2020
08:57Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
相关概念视频
Tagging and Fusion Proteins
Protein Complexes with Interchangeable Parts
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Protein Families
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
